vs
Side-by-side financial comparison of Ovid Therapeutics Inc. (OVID) and Reborn Coffee, Inc. (REBN). Click either name above to swap in a different company.
Reborn Coffee, Inc. is the larger business by last-quarter revenue ($1.4M vs $718.0K, roughly 1.9× Ovid Therapeutics Inc.). On growth, Ovid Therapeutics Inc. posted the faster year-over-year revenue change (844.7% vs 7.8%). Over the past eight quarters, Ovid Therapeutics Inc.'s revenue compounded faster (120.3% CAGR vs 0.1%).
Reborn Coffee, Inc. is a specialty coffee roaster and retailer that offers premium single-origin and blended roasted coffee beans, handcrafted espresso drinks, baked snacks and related merchandise. It operates brick-and-mortar cafe locations primarily across the United States, alongside direct-to-consumer online sales and wholesale distribution to foodservice partners, with a core focus on ethically sourced, high-quality coffee products.
OVID vs REBN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | ||
|---|---|---|
| Revenue | $718.0K | $1.4M |
| Net Profit | — | $-3.4M |
| Gross Margin | — | — |
| Operating Margin | — | -224.7% |
| Net Margin | — | -254.3% |
| Revenue YoY | 844.7% | 7.8% |
| Net Profit YoY | 204.4% | -379.3% |
| EPS (diluted) | — | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $718.0K | — | ||
| Q3 25 | $132.0K | $1.4M | ||
| Q2 25 | $6.3M | $1.8M | ||
| Q1 25 | $130.0K | $1.7M | ||
| Q4 24 | $76.0K | $1.8M | ||
| Q3 24 | $173.0K | $1.3M | ||
| Q2 24 | $169.0K | $1.4M | ||
| Q1 24 | $148.0K | $1.5M |
| Q4 25 | — | — | ||
| Q3 25 | $-12.2M | $-3.4M | ||
| Q2 25 | $-4.7M | $-5.3M | ||
| Q1 25 | $-10.2M | $-2.2M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | $-14.0M | $-719.7K | ||
| Q2 24 | $8.5M | $-1.3M | ||
| Q1 24 | $-11.7M | $-990.5K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 98.7% |
| Q4 25 | — | — | ||
| Q3 25 | -9487.1% | -224.7% | ||
| Q2 25 | -80.9% | -240.2% | ||
| Q1 25 | -9653.8% | -100.2% | ||
| Q4 24 | — | -95.2% | ||
| Q3 24 | -7645.1% | -57.6% | ||
| Q2 24 | -12140.2% | -97.4% | ||
| Q1 24 | -11768.2% | -56.9% |
| Q4 25 | — | — | ||
| Q3 25 | -9210.6% | -254.3% | ||
| Q2 25 | -74.7% | -291.0% | ||
| Q1 25 | -7873.1% | -129.4% | ||
| Q4 24 | — | -100.0% | ||
| Q3 24 | -8096.0% | -57.2% | ||
| Q2 24 | 5042.0% | -95.9% | ||
| Q1 24 | -7901.4% | -65.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.68 | ||
| Q2 25 | — | $-1.15 | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | — | $-0.28 | ||
| Q3 24 | $-0.20 | $-0.30 | ||
| Q2 24 | $0.12 | $-0.48 | ||
| Q1 24 | $-0.17 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.2M | $44.0K |
| Total DebtLower is stronger | — | $500.0K |
| Stockholders' EquityBook value | $130.7M | $-3.4M |
| Total Assets | $150.9M | $6.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.2M | — | ||
| Q3 25 | $20.6M | $44.0K | ||
| Q2 25 | $28.4M | $77.9K | ||
| Q1 25 | $21.1M | $777.1K | ||
| Q4 24 | $26.3M | $158.2K | ||
| Q3 24 | $15.0M | $105.9K | ||
| Q2 24 | $29.7M | $617.1K | ||
| Q1 24 | $30.8M | $70.3K |
| Q4 25 | — | — | ||
| Q3 25 | — | $500.0K | ||
| Q2 25 | — | $500.0K | ||
| Q1 25 | — | $500.0K | ||
| Q4 24 | — | $500.0K | ||
| Q3 24 | — | $500.0K | ||
| Q2 24 | — | $500.0K | ||
| Q1 24 | — | $500.0K |
| Q4 25 | $130.7M | — | ||
| Q3 25 | $44.7M | $-3.4M | ||
| Q2 25 | $55.8M | $-1.9M | ||
| Q1 25 | $59.3M | $415.6K | ||
| Q4 24 | $68.2M | $2.6M | ||
| Q3 24 | $76.3M | $2.7M | ||
| Q2 24 | $88.9M | $2.5M | ||
| Q1 24 | $78.3M | $2.6M |
| Q4 25 | $150.9M | — | ||
| Q3 25 | $63.8M | $6.2M | ||
| Q2 25 | $77.4M | $6.4M | ||
| Q1 25 | $81.7M | $8.1M | ||
| Q4 24 | $92.2M | $7.8M | ||
| Q3 24 | $102.7M | $9.6M | ||
| Q2 24 | $118.1M | $10.5M | ||
| Q1 24 | $131.6M | $10.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.19× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-38.3M | $-1.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-38.3M | — | ||
| Q3 25 | $-12.9M | $-1.6M | ||
| Q2 25 | $-4.8M | $-3.6M | ||
| Q1 25 | $-10.3M | $464.6K | ||
| Q4 24 | $-56.0M | $-132.6K | ||
| Q3 24 | $-15.0M | $-424.0K | ||
| Q2 24 | $-14.3M | $-961.8K | ||
| Q1 24 | $-16.7M | $-1.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-56.0M | $-600.9K | ||
| Q3 24 | $-15.0M | $-424.0K | ||
| Q2 24 | $-14.3M | $-1.3M | ||
| Q1 24 | $-16.7M | $-2.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -73719.7% | -33.8% | ||
| Q3 24 | -8676.9% | -33.7% | ||
| Q2 24 | -8455.0% | -95.3% | ||
| Q1 24 | -11287.2% | -192.4% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 93.4% | 26.3% | ||
| Q3 24 | 2.3% | 0.0% | ||
| Q2 24 | 20.1% | 25.2% | ||
| Q1 24 | 12.8% | 65.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.67× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OVID
Segment breakdown not available.
REBN
| Stores | $1.1M | 83% |
| Other | $229.9K | 17% |